EUROAPI

💊 #Irbesartan: European expertise at its best! For more than 20 years, at its Budapest industrial site, #EUROAPI has been manufacturing Irbesartan, an active pharmaceutical ingredient mainly used for the treatment of hypertension.   ♻ In line with our commitment to minimizing the environmental footprint of our activities, a #recycling process is set up for this production: solvents are reused and recycled.   And did you know? 🏭 With a dedicated production line and large industrial capacities, EUROAPI is the largest European producer of Irbesartan supplying the market.   In a nutshell, Irbesartan manufactured by EUROAPI: ✅ Made in Europe ✅ Vertical integration on key raw materials ✅ Large industrial capacities ✅ Supportive regulatory dossiers: CEP, C-DMF and USDMF in progress   📧 Any questions? Feel free to contact us! 👉 contact@euroapi.com 👉 https://lnkd.in/ebtyCefs   #APIsolutions #activesolutionsforhealth #solventsrecycling

[📄 Article] - #ESG & #Innovation: Driving Sustainable Progress in R&D We are excited to share our latest article published in #ChemistryToday journal. In this story, Laurent Petit, Head of Innovation and External Collaborations at #EUROAPI, outlines how EUROAPI integrates #ESG into its research and development processes, setting ambitious goals and pioneering new methodologies to ensure sustainable progress.   “To achieve our ambitious goals, we developed a comprehensive implementation strategy. This included defining the indicators, establishing processes to evaluate them, and creating user-friendly tools to facilitate their application. Several tools were evaluated and tested on several complex molecules in our portfolio,” Laurent Petit writes.   Full article 👉 https://lnkd.in/gvWTkH5R Enjoy your reading!   🌿 Check out our #ESGcommitments 👉 https://lnkd.in/ewPrAX7C   #environmentalinnovations #ESGgoals #ESGefforts #sustainablepractices #sustainableprocesses

🇪🇺 Renforcement de la souveraineté sanitaire européenne : participez à la discussion ! L’Europe peut-elle être autonome en produits de #santé ? Quels leviers pour une production d’avenir ? Sylvia Cabrillac-Rives, Directrice de la stratégie d’EUROAPI apportera son éclairage lors du colloque organisé par #Pharmaceutiques et #PariSantéCampus. Inscrivez-vous ! #souveraineté #chimie #criticalmedicinesalliance

🚀 EUROAPI at #DCATWeek 2025: Strengthening Partnerships & Breaking Records! We were thrilled to participate in #DCATWeek, engaging in insightful discussions and strengthening key partnerships. As our CEO David Seignolle highlighted: “This week was very much around our customers and we can best serve them. I am very proud of the team result of hosting a record high number of meetings! So many customers are very enthusiastic and interested into our capabilities, driving exciting CDMO prospects ; especially our Peptides and Oligonucleotides platform.” A huge thank you to everyone who visited us, exchanged ideas, and showed interest in our expertise! 💊 #DCATWeek #CDMO #apisolutions

#DCATWeek is in full swing! 🤝 Feel free to drop by anytime in our Suites 5208 and 5217 - Lotte New York Palace.  #apisolutions #CDMO  

[#ESG] – #GlobalRecyclingDay ♻ Discover a few of EUROAPI’s recycling efforts to reduce the impact on our planet!   EUROAPI and its employees work every day on reducing waste, promoting sustainable practices and highlighting the benefits of #recycling and reusing: ✅ A Responsible Innovation Program was launched to boost environmentally friendly projects, such as setting up a recycling process for several compounds ✅ 70+% of our solvents are recycled ✅ At our industrial sites, we clean and reuse plastic drums: ~10,000 drums saved and reused at our Vertolaye site in France and 1,800 drums at our Budapest site.   Find out more about our ESG commitments ➡https://lnkd.in/gmh4CkFu 🌿 #AchievingTogether. Join us on this Recycling journey!

Critical Medicines Act, une avancée prometteuse mais encore trop timide ! 💊 Sur les médicaments critiques, l’autonomie stratégique de l’Europe doit être assumée, chiffrée et objectivée. Lien vers le texte du CMA : https://bit.ly/4iqtjYa

[#NextGenBiomed2025] 🙏 Thanks for attending the EUROAPI session about ‘#Peptides in various combinations of drug modalities’ presented by Kerstin Jahn-Hofmann and Mark Macdonald. If you missed the presentation or if you have any questions, do not hesitate to reach out to us. Our experts will be more than happy to provide you with detailed information about our #tide capabilities: 👉 contact@euroapi.com 👉 https://lnkd.in/ebtyCefs #cdmo #oligonucleotides

EUROAPI is excited to announce that we will attend #CPHIJapan2025 - April 9-11 (Tokyo Big Sight, Japan). 🤝 Don’t miss the chance to connect with our team! Stop by our Booth #5P-10. The EUROAPI team will be delighted to introduce our API portfolio and our #CDMO capabilities to you. 📧 To schedule a meeting with our team: 👉 contact@euroapi.com 👉 https://lnkd.in/ebtyCefs Let’s discuss your projects! #apisolutions #activepharmaceuticalingredients

#NextGenBiomed2025 is now open!   🤝 Come and meet us in London (March 12-14). The EUROAPI team is looking forward to welcoming you to our stand #42.   📅 And don’t miss our presentation about ‘#Peptides in various combinations of drug modalities’ on March 14th at 14:15 (conference room 5).   See you soon!   #cdmo #tides #oligonucleotides